In this post in the Center for Global Development’s (CGD) “Global Health Policy” blog, Victoria Fan, a research fellow at the Center for Global Development (CGD), and Felix Lam, a malaria research analyst, examine the discrepancies between the WHO’s estimated number of malaria deaths worldwide and the data recently released by the Institute for Health Metrics and Evaluation (IHME). They ask, “Given the 1.2 billion dollars by donors to malaria in 2010, is it unreasonable to demand to know with more certainty, how many people are dying from malaria?” and go on to describe how each group analyzed data to get to their conclusions (2/9).
USAID on Monday said it has “delivered the first two of 17 planned laboratory devices” to help quickly diagnose drug-resistant strains of tuberculosis (TB), VOA’s “Breaking News” blog reports. “It says the machines allow for technicians to diagnose multi-drug resistant tuberculosis within as little as two hours, instead of the previous time requirement of several months,” the blog writes. The “new lab devices, along with 12,000 testing cartridges, will be given to tuberculosis hospitals and clinics in more than 10 Vietnamese provinces,” according to the news service (2/6).
Noting “there is a huge ‘cancer divide’ between rich and poor,” with more than half of new cancer cases and almost two-thirds of all cancer deaths occurring in developing countries, this year’s World Cancer Day theme, “Together It Is Possible,” “calls on all individuals, organizations and governments to do their part to reduce premature deaths from cancers by 25 percent by 2025,” Felicia Knaul, secretariat for the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, and Jonathan Quick, president of Management Sciences for Health, write in a Huffington Post opinion piece. “But there have been four myths that have held back cancer care and control in developing countries,” they write.
“Early diagnosis is the key to reducing the nearly eight million deaths caused by cancer across the globe annually, the United Nations World Health Organization (WHO) said” on Saturday to mark World Cancer Day, “stressing the importance of screening programs for healthy people to detect the disease promptly for easier treatment,” the U.N. News Centre reports (2/3). The theme of this year’s day, which is recognized annually on February 4, was “Together It Is Possible,” “reinforcing that it is only by every person, organization, and government individually doing their part that the world will be able to reduce premature deaths from cancer and other non-communicable diseases,” according to a press release from the International Agency for Research on Cancer (2/4). The WHO “reminded the world that cancer is responsible for close to 13 percent of deaths globally, accounting for 7.6 million deaths in 2008,” according to the U.N. News Centre (2/3).
The WHO has disputed a study published last week in the Lancet “that claims nearly twice as many people are dying of malaria than current estimates,” VOA News reports. The WHO “says both its estimates of malaria deaths and those of the Lancet study are statistically the same for all groups in all regions,” with one exception, VOA writes, noting, “WHO spokesman Gregory Hartl says there’s a notable statistical difference in regard to children over five and adults in Africa.”
“[T]he highest levels ever of drug-resistant tuberculosis (TB) have been found in Russia and Moldova,” the WHO reports in research published in the February edition of the WHO Bulletin, but “the agency didn’t have data from most of Africa and India, where tuberculosis rates are much higher,” the Associated Press/USA Today’s “Your Life” reports. According to the AP, the “experts reported that about 29 percent of new TB patients in parts of Russia were drug-resistant” and that “65 percent of previously treated patients in Moldova had resistance problems.” The news service notes, “Normally, less than five percent of TB cases are drug-resistant” (2/2).
As part of a week-long series, titled “Generation Positive,” looking at the HIV epidemic in the U.S. and Washington, D.C., WTOP’s Thomas Warren examines the history of HIV/AIDS in the U.S. compared with Germany, where he traveled as a fellow with the RIAS Berlin Kommission. The article describes “the history of HIV in Germany, including the governmental policies aimed at handling the disease and how the virus is treated medically,” according to the introduction (Warren, 2/1).
“There have been 1,623 cases of all strains of flu in Mexico recorded so far for January, 90 percent of them H1N1 [swine flu],” compared to “about 1,000 flu cases in Mexico during all of last year,” of which roughly 250 cases were swine flu, Health Secretary Salomon Chertorivski Woldenberg told reporters on Tuesday, the Associated Press reports. The news service notes, “Despite the spike, the number of cases is well within a normal flu season for Mexico, which can see from 5,000 to 11,000 incidents of all strains,” Woldenberg said. “The low appearance of the H1N1 virus the past two years is one reason it’s drawing so much media attention in Mexico,” the AP writes, adding, “Public nervousness about H1N1 has been high since the first outbreak in spring 2009, when the virus initially appeared to have a high mortality rate and Mexican authorities closed restaurants, schools, museums, libraries, and theaters to stop its spread” (2/1).
“A pilot community program to improve [tuberculosis (TB)] detection in northern Tanzania has shown good results and could be replicated nationwide as the country seeks to improve its TB treatment and prevention systems,” IRIN reports. The program, run by Management Sciences for Health with help from PATH and Tanzania’s National Tuberculosis and Leprosy Programme and financial support from USAID, “emphasized that TB and HIV treatment must be done ‘hand in hand,'” according to IRIN.
This post in the Malaria Free Future blog reports on a study underway in Rwanda that aims to measure the prevalence of malaria in pregnancy (MIP). The research is supported by the U.S. President’s Malaria Initiative (PMI) and is being carried out through its Maternal and Child Health Integrated Program (MCHIP) “so that the National Malaria Control Program (NMCP) can have data to design appropriate MIP interventions as the country moves towards malaria elimination,” the blog notes. According to the blog, the study of more than 4,000 women “focuses on pregnant women during their first visit to focused antenatal care (FANC) for their current pregnancy” and is currently at the half way mark (Brieger, 1/25).